Novo Nordisk's Wegovy gets UK approval for use to lower heart risks - Reuters
- Novo Nordisk's Wegovy gets UK approval for use to lower heart risks Reuters
- Weight-loss drug given green light to tackle heart problems BBC
- MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults GOV.UK
- Wegovy: Weight-loss jab approved for use in preventing heart attacks and strokes in UK Sky News
- Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment CNBC